Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule; laboratory test coding, pricing, coverage, and payment; implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform; artificial intelligence in laboratory services; utilization management, including prior authorization policies impacting clinical laboratories.
2025 · 2nd Quarter (Apr 1 - June 30)
AMERICAN CLINICAL LABORATORY ASSN
Filed by AMERICAN CLINICAL LABORATORY ASSN.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Amendment
- Posted
- Oct 17, 2025
- Income
- Not reported
- Expenses
- $510,000.00
- Registrant
- AMERICAN CLINICAL LABORATORY ASSN
- Filing UUID
- d48250b3-4e97-4180-be8a-2c87b228d00a
- Termination date
- Not reported
Expense method: C
Literal source text
Lobbying issues and bill citations
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule; laboratory test coding, pricing, coverage, and payment; implementation of the Protecting Access to Medicare Act (P.L. 113-93).
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule; laboratory test coding, pricing, coverage, and payment; implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostics regulatory reform; FDA and CMS policies related to diagnostics and laboratory regulation; price transparency requirements for clinical laboratory services.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.